Abstract
New Therapeutic Targets is the theme of articles in the Annual Review of Pharmacology and Toxicology, Volume 59. Reviews in this volume discuss targets for a variety of conditions in need of new therapies, including type 2 diabetes, heart failure with preserved ejection fraction, obesity, thyroid-associated ophthalmopathy, tinnitus, multiple sclerosis, Parkinson's disease and other neurodegenerative diseases, pain, depression, post-traumatic stress disorder, muscle wasting diseases, cancer, and anemia associated with chronic renal disease. Numerous articles in this volume focus on the identification, validation, and utility of novel therapeutic targets, in particular, ones that involve new or unexpected molecular entities. This theme complements several previous themes, including New Approaches for Studying Drug and Toxicant Action: Applications to Drug Discovery and Development, Precision Medicine and Prediction in Pharmacology, and New Methods and Novel Therapeutic Approaches in Pharmacology and Toxicology.
Cite
CITATION STYLE
Insel, P. A., Amara, S. G., Blaschke, T. F., & Meyer, U. A. (2019, January 6). Introduction to the theme new therapeutic targets. Annual Review of Pharmacology and Toxicology. Annual Reviews Inc. https://doi.org/10.1146/annurev-pharmtox-101018-112717
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.